2023
DOI: 10.1016/j.neurol.2022.09.006
|View full text |Cite
|
Sign up to set email alerts
|

Paradigm shifts in multiple sclerosis management: Implications for daily clinical practice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 76 publications
0
2
0
Order By: Relevance
“…Notably, in the presence of complex and heterogeneous data, as happened in MS disease, patient stratification is a strong prerequisite for effective personalized medicine, as disease development is frequently driven by individual variability and unpredictable environmental events [82,83]. Thus, the use of personalized medicine to develop novel therapeutic strategies tailored to the individual patients' characteristics and the specific disease activity features, as well as to the patients' needs and preferences, may bring about novel challenges and perspectives [59,82,83].…”
Section: Multivariate Analysis Of MD Compliance By Adjusting For Pote...mentioning
confidence: 99%
See 1 more Smart Citation
“…Notably, in the presence of complex and heterogeneous data, as happened in MS disease, patient stratification is a strong prerequisite for effective personalized medicine, as disease development is frequently driven by individual variability and unpredictable environmental events [82,83]. Thus, the use of personalized medicine to develop novel therapeutic strategies tailored to the individual patients' characteristics and the specific disease activity features, as well as to the patients' needs and preferences, may bring about novel challenges and perspectives [59,82,83].…”
Section: Multivariate Analysis Of MD Compliance By Adjusting For Pote...mentioning
confidence: 99%
“…There are also diverse modifiable risk factors, such as obesity, lack of exercise, alcohol consumption, and smoking, which may increase the risk of the development and/or management of MS [57,58]. Both modifiable comorbidities and risk factors may differently affect the course and the progression of MS, highlighting the need for more personalized treatment approaches for each MS patient separately [59].…”
Section: Introductionmentioning
confidence: 99%